| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| Cost of Revenue | $0 | — | -100.0% |
| Gross Profit | $0 | — | — |
| R&D Expense | $2.3M | — | +100.4% |
| SG&A Expense | $128K | — | +4.1% |
| Operating Income | -$3.5M | — | -38.1% |
| Net Income | -$3.5M | — | -36.5% |
| EPS (Basic) | $0.07 | — | +16.7% |
| EPS (Diluted) | $0.07 | — | +16.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.1M | -41.8% | -67.1% |
| Current Assets | $12.5M | -18.3% | -41.1% |
| Total Assets | $13.1M | -17.9% | -39.2% |
| Current Liabilities | $1.6M | -28.5% | -2.9% |
| Total Liabilities | $2.4M | -15.6% | +10.0% |
| Stockholders' Equity | $10.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.1M | — | -120.1% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $130K | — | -99.0% |
| Free Cash Flow | -$3.1M | — | -118.8% |
| -44.9% |